Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk

Critical Care Medicine

Volumn 24, Issue 3, 1996, Pages 392-397

  Borrelli, Emma ^a   Roux Lombard, Pascale ^a   Grau, Georges E ^a   Girardin, Eric ^a   Ricou, Bara ^a   Dayer, Jean Michel ^a   Suter, Peter M ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

antioxidants; copper; critical illness; cytokines; multiple organ failure; TNF soluble receptors; tumor necrosis factor; vitamin C; vitamin E; zinc

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; COPPER; CYTOKINE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; ZINC;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIOXIDANTS; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, CYTOKINE; RISK FACTORS; SOLUBILITY; VITAMINS;

EID: 0029997657     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199603000-00006     Document Type: Article

References (38)

1. Mc Menany RC, Birkhan R, Oswald G, et al: Multi-system organ failure. 1. The basal state. J Trauma 1981; 21:99-114
2. Goris RJA, Boekhorst PA, Nuytink JKS, et al: Multiple organ failure: Generalized autodestructive inflammation? Arch Surg 1985; 120:1109-1115
3. Goris RJA, Boekhorst PA, Van Bebber IPT, et al: Multiple organ failure and sepsis without bacteria. Arch Surg 1986; 121:897-901
4. La Londe C, Demling RH, Goad MEP: Tissue inflammation without bacteria produces increased oxygen consumption and distant organ lipid peroxidation. Surgery 1988; 7:49-56
5. Van Bebber IPT, Boekholz WKF, Goris RJA, et al: Neutrophil function and lipid peroxidation in a rat model of multiple organ failure. J Surg Res 1989; 47:471-475
6. Debets JM, Kampmejer R, Van der Linden MP, et al: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 1989; 17: 489-494
7. Calandra T, Baumgartner JD, Grau GE, et al: Kinetics and prognostic values of tumor necrosis factor/cachectin, interleukin-1, α-interferon and gamma-interferon in the serum of patients with septic shock. J Infect Dis 1990; 161:982-987
8. Seckinger P, Isaaz S, Dayer JM: A human inhibitor of tumor necrosis factor. J Exp Med 1988;167:1511-1516
9. Seckinger P, Zhang JH, Hauptmann B, et al: Characterisation of a TNF-α inhibitor. Evidence of immunological cross-reactivity with the TNF receptors. Proc Natl Acad Sci USA 1990; 87:5188-5192
10. Van Zee KJ, Kohno T, Fischer E, et al: Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc Natl Acad Sci USA 1992; 89:4845-4849
11. Girardin E, Grau GE, Dayer JM, et al: Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988; 319:397-400
12. Damas P, Reuter A, Gysen P, et al: Tumor necrosis factor and interleukin-1 levels during severe sepsis in humans. Crit Care Med 1989; 17:975-978
13. Marty C, Misset B, Tamion F, et al: Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994; 22:673-679
14. Roumen RMH, Hendriks T, Van der Ven-Jongekrijg J, et al: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993; 218:769-776
15. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103:565-575
16. Damas P, Ledoux D, Nys M, et al: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215:356-362
17. Calandra Th, Gerain J, Heumann D, et al: High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 1991; 91:23-29
18. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119:771-778
19. Guo Y, Dickerson C, Chrest FJ, et al: Increased levels of circulating interleukin 6 in burn patients. Clin Immunol Immunopathol 1990; 54:361-371
20. Ertel W, Morrison MH, Wang P, et al: The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin, and interleukins. Ann Surg 1991; 214:141-148
21. Freeman BA, Crapo JD: Biology of disease: Free radicals and tissue injury. Lab Invest 1982; 47:412-426
22. Maderazo EG, Woronick CL, Hickingbotham N, et al: Additional evidence of autoxidation as a possible mechanism of neutrophil locomotry dysfunction in blunt trauma. Crit Care Med 1990; 18:141-147
23. Goode HF, Webster NR: Free radicals and trace element metabolism in sepsis and injury. Br J Intensive Care 1992; 2: 312-322
24. Leff JA, Parsons PE, Day CE, et al: Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 1993; 341:777-780
25. Packer JE, Slater TF, Wilson RL: Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979; 278:737-738
26. L'Abbé MR, Fischer PWF: The effect of high dietary zinc and copper deficiency on the activity of copper requiring metalloenzymes in the growing rat. J Nutr 1988; 114:813-822
27. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1992; 20:934-941
28. Margolis SA, Davis TP: Stabilisation of ascorbic acid in human plasma and its liquid chromatographic measurement. Clin Chem 1988; 34:17-23
29. Burton GW, Webb A, Ingold KV: A mild rapid and efficient method of lipid extraction for use in determining vitamin E/lipid ratios. Lipids 1985; 20:29-39
30. Roten R, Markert M, Feihl F, et al: Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am Rev Respir Dis 1991; 143: 590-592
31. Banks RE, Evans SW, Alexander D, et al: Is fatal pancreatitis a consequence of excessive leukocyte stimulation? The role of tumor necrosis factor. Cytokine 1991; 3:13-16
32. Villard J, Roux-Lombard P, Hugli A, et al: Could natural inhibitors of tumor necrosis factor-α modify the clinical course of fulminant meningococcemia? Crit Care Med 1993; 21:1396-1400
33. Porat R, Paddock HN, Schwaitzberg SD, et al: Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis. Crit Care Med 1995; 23:1080-1089
34. Nijsten MWN, De Groot ER, Ten Duis HJ, et al: Serum level of interleukin 6 and acute phase responses. Lancet 1987; ii:921
35. Frei B, Stocker R, Ames BN: Antioxidant defenses and lipid peroxidation in blood plasma. Proc Natl Acad Sci USA 1988; 85:9748-9752
36. Goode HF, Cowley HC, Waler BE, et al: Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995; 23: 646-651
37. Halliwell B, Gutteridge JMC: Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219: 1-14
38. Taylor CG, Bettger WJ, Bray TM: Effect of dietary zinc or copper deficiency on the primary free radical defense system in rats. J Nutr 1988; 118:613-621